No insider purchase over the last 90 days. The latest, by Siokas Grigorios, was filed 12 Oct 2023.
Cosmos Holdings Inc.: what insiders have been doing
Cosmos Holdings Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Cosmos Holdings Inc. has published a filing in the past twelve months. The most recent one dates from 22 December 2023.
Over the whole record (from 2018), the tally stands at 13 purchases and 2 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Cosmos Holdings Inc. Strong Buy (bullish), based on 1 analysts. Average price target: US$4.50.
Top signal score 29 of 100
Buys €10M€698,389 Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 26,019 of 26,248 companies
6.6
score / 100
Value
6
Quality
8
FCF yld-29%
Earn yld-65%
EV/EBITDA·
ROE-104%
Gross mgn12%
Net mgn-29%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
71,875 shares@ US$3.9715.4% of flowCommon Stock, par value $0.001 per shareSEC:0001477932-18-005061:0
23 of 23 declarations
About Cosmos Holdings Inc.
Cosmos Holdings Inc. is a NASDAQ-listed company that specializes in the distribution of pharmaceutical and health products. It focuses on the sourcing and sale of medications and nutritional supplements.